Analysts rate Senseonics Holdings Inc. (SENS:NYE) with a Strong Buy rating and a $3 target

STA Research
by: STA Research
SENS stock

Based on the Senseonics stock forecast from 1 analyst, the average analyst SENS stock price target is USD 3.00 over the next 12 months. Senseonics Holdings Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of SENS stock forecast is Slightly Bullish, which is based on 5 positive signals and 4 negative signals. At the last closing, Senseonics stock price was USD 1.28Senseonics stock price has changed by -0.28% over the past week, -0.42% over the past month and -65.68% over the last year.


About Senseonics Holdings Inc. (SENS:NYE):

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company’s products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.


Most Recent Analyst Ratings for SENS Stock:

Maintains HC Wainwright Buy USD 6 » USD 3 2022-07-25
Initiates Coverage On HC Wainwright Buy USD 6 2021-08-19
Downgraded by SVB Leerink Outperform » Mkt Perform USD 3 2021-04-01
Target Raised by Stifel Nicolaus Research Buy USD 1 » USD 2.5 2021-03-05
Target Raised by SVB Leerink Outperform USD 1 » USD 3 2021-03-05
Downgrades Raymond James Capital Underperform 2021-03-05
Reiterated by Stifel Nicolaus Research Buy USD 1.85 2021-01-26
Downgrades BTIG Research Neutral 2021-01-21
Downgrades Craig Hallum Sell 2021-01-20
Reiterated by Raymond James Capital Hold 2020-08-16
Upgrades BTIG Research Buy USD 1 2020-08-11
Upgrades Craig Hallum Hold 2020-08-11
Target Lowered by SVB Leerink Outperform USD 2 » USD 1 2020-06-10
Target Lowered Stifel Nicolaus Research Buy USD 1.85 » USD 1 2020-06-10
Reiterated by BTIG Research Hold 2020-06-10
Target Lowered by UBS Sell USD 0.7 » USD 0.25 2020-05-21
Downgraded by BTIG Research Buy » Neutral 2020-03-13
Downgraded by Guggenheim Securities Buy » Neutral 2020-03-13
Target Lowered by Canaccord Capital Hold USD 1 » USD 0.75 2020-03-13
Reiterates Peel Hunt Buy 2019-11-15
Reiterates Liberum Capital Buy 2019-11-15
Maintains UBS Sell USD 1 » USD 0.75 2019-11-13
Downgrades Canaccord Capital Buy » Hold USD 2 » USD 1 2019-11-13
Downgrades Craig Hallum Buy » Hold USD 2.5 2019-11-13
Initiates Coverage On Stifel Nicolaus Research Buy USD 2 2019-10-23



What we like:

Underpriced compared to earnings:

SENS stock price is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior capital utilization:

Senseonics stock management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive free cash flow:

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth:

SENS stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth:

SENS stock has shown top quartile revenue growth in the previous 5 years compared to its sector.


What we don’t like:

Low market capitalization:

SENS stock is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

High volatility:

The total returns for SENS stock are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to book value:

SENS stock price is trading high compared to its peers median on a price to book value basis.

Negative cashflow:

The company had negative total cash flow in the most recent four quarters.




Stock Target Advisor is not a broker/dealer, investment advisor, or platform for making stock buying or selling decisions. Our goal is to democratize and simplify financial information through automated analysis, aggregation of stock information, and education to help investors with their research. No content on our site, blogs or newsletters constitutes – or should be understood as constituting – a recommendation to enter into any securities transactions or to engage in any of the investment strategies presented in our site content. We also cannot guarantee the accuracy of any information presented on our site and in our analysis.

Leave a Reply

Your email address will not be published.